XSLV vs. CDC
XSLV (Invesco S&P SmallCap Low Volatility ETF) and CDC (VictoryShares US EQ Income Enhanced Volatility Wtd ETF) are both Low Volatility funds - XSLV tracks the S&P SmallCap 600 Low Volatility Index while CDC tracks the Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. Both are passively managed. Over the past 10 years, XSLV returned 6.00%/yr vs 10.37%/yr for CDC. Their 0.77 correlation means they have sometimes moved together and sometimes differently. XSLV charges 0.25%/yr vs 0.37%/yr for CDC.
Performance
XSLV vs. CDC - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both investments are quite close, with XSLV having a 16.90% return and CDC slightly higher at 17.48%. Over the past 10 years, XSLV has underperformed CDC with an annualized return of 6.00%, while CDC has yielded a comparatively higher 10.37% annualized return.
XSLV
- 1D
- 0.11%
- 1M
- 1.52%
- 6M
- 12.18%
- YTD
- 16.90%
- 1Y
- 23.10%
- 3Y*
- 10.59%
- 5Y*
- 4.97%
- 10Y*
- 6.00%
- ALL TIME*
- 8.21%
CDC
- 1D
- -0.37%
- 1M
- 0.43%
- 6M
- 10.50%
- YTD
- 17.48%
- 1Y
- 22.44%
- 3Y*
- 13.45%
- 5Y*
- 6.78%
- 10Y*
- 10.37%
- ALL TIME*
- 10.00%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.05M | $965.48K | $1.21M | |
| $818.81K | $536.56K | $433.11K |
XSLV vs. CDC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
XSLV Invesco S&P SmallCap Low Volatility ETF | 16.90% | 0.31% | 9.81% | 1.34% | -11.83% | 29.34% | -17.40% | 22.35% | -5.41% | 8.57% |
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 17.48% | 8.96% | 14.48% | -4.99% | -7.86% | 33.05% | 12.88% | 19.64% | -5.97% | 15.77% |
Correlation
The correlation between XSLV and CDC is 0.72, which is moderate. They have sometimes moved together and sometimes differently, sharing some price drivers without tracking each other closely.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.72 |
Correlation (3Y) Balances recent behavior with more history. | 0.73 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.76 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.77 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 2014 | 0.77 |
The correlation between XSLV and CDC has been stable across timeframes, ranging from 0.72 to 0.77 - a consistent structural relationship.
XSLV vs. CDC - Sectors Allocation Comparison
Sectors
XSLV
CDC
Financial Services
Real Estate
Utilities
Industrials
Consumer Defensive
Basic Materials
Healthcare
Consumer Cyclical
Communication Services
Energy
Technology
Financial Services
XSLV
CDC
Real Estate
XSLV
CDC
Utilities
XSLV
CDC
Industrials
XSLV
CDC
Consumer Defensive
XSLV
CDC
Basic Materials
XSLV
CDC
Healthcare
XSLV
CDC
Consumer Cyclical
XSLV
CDC
Communication Services
XSLV
CDC
Energy
XSLV
CDC
Technology
XSLV
CDC
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XSLV vs. CDC — Risk / Return Rank
XSLV
CDC
XSLV vs. CDC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P SmallCap Low Volatility ETF (XSLV) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XSLV | CDC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.47 | ||
| Sortino ratioReturn per unit of downside risk | -0.65 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.36 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 3.00 | 3.90 | -0.90 |
| Martin ratioReturn relative to average drawdown | 8.88 | 13.80 | -4.92 |
Loading charts...
Drawdowns
XSLV vs. CDC - Drawdown Comparison
The maximum XSLV drawdown since its inception was -44.34%, which is greater than CDC's maximum drawdown of -21.37%. Use the drawdown chart below to compare losses from any high point for XSLV and CDC.
Loading charts...
Drawdown Indicators
| XSLV | CDC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -44.34% | -21.37% | -22.97% |
Max Drawdown (1Y)Largest decline over 1 year | -7.46% | -5.67% | -1.79% |
Max Drawdown (3Y)Largest decline over 3 years | -18.35% | -12.70% | -5.65% |
Max Drawdown (5Y)Largest decline over 5 years | -24.72% | -21.37% | -3.35% |
Max Drawdown (10Y)Largest decline over 10 years | -44.34% | -21.37% | -22.97% |
Current DrawdownCurrent decline from peak | -1.13% | -2.22% | +1.09% |
Average DrawdownAverage peak-to-trough decline | -7.21% | -5.05% | -2.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.51% | 1.60% | +0.91% |
Volatility
XSLV vs. CDC - Volatility Comparison
Invesco S&P SmallCap Low Volatility ETF (XSLV) and VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) have volatilities of 4.04% and 4.16%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XSLV | CDC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.04% | 4.16% | -0.12% |
Volatility (6M)Calculated over the trailing 6-month period | 9.46% | 7.81% | +1.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.39% | 10.33% | +3.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.70% | 12.57% | +4.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.93% | 13.21% | +6.72% |
XSLV vs. CDC - Expense Ratio Comparison
XSLV has a 0.25% expense ratio, which is lower than CDC's 0.37% expense ratio.
Dividends
XSLV vs. CDC - Dividend Comparison
XSLV's dividend yield for the trailing twelve months is around 2.06%, less than CDC's 3.06% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CDC VictoryShares US EQ Income Enhanced Volatility Wtd ETF | 3.06% | 3.36% | 3.32% | 4.24% | 3.48% | 2.65% | 2.48% | 3.04% | 3.37% | 2.81% | 2.99% | 3.17% |
XSLV Invesco S&P SmallCap Low Volatility ETF | 2.06% | 2.14% | 2.55% | 2.35% | 2.78% | 1.05% | 2.49% | 2.43% | 2.75% | 1.87% | 1.96% | 2.20% |
Frequently Asked Questions
XSLV and CDC have a correlation of 0.72, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CDC has higher volatility (4.16%) compared to XSLV (4.04%). In terms of maximum drawdown, XSLV dropped -44.34% vs CDC's -21.37%.
On 10-year performance, CDC leads with 10.37% vs 6.00% for XSLV. On fees, XSLV is cheaper at 0.25% per year. On volatility, XSLV has been the lower-risk option at 4.04%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CDC has performed better with a 10.37% return vs 6.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XSLV is cheaper with a 0.25% expense ratio, compared with 0.37% for CDC.
CDC has the higher dividend yield at 3.06%, compared with 2.06% for XSLV.
XSLV tracks S&P SmallCap 600 Low Volatility Index, while CDC tracks Nasdaq Victory U.S. Large Cap High Dividend 100 Long/Cash Volatility Weighted Index. They also come from different issuers: Invesco and Crestview. Their fees differ too: 0.25% for XSLV and 0.37% for CDC.
CDC currently has the higher Sharpe Ratio (2.14 vs 1.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XSLV and CDC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer